Case Files 1-6 (C) Flashcards
(78 cards)
Screening tests for cardiovascular conditions
- Blood pressure measurement (HTN)
- Lipid measurement (dyslipidemia)
Recommendations for:
Influenza vaccine
Tetanus vaccine
Annually and every 10 years, respectively
Intervention designed to prevent a disease before it occurs
Primary prevention
Examples:
Statin medication to reduce LDL in order to lower the risk of CAD
Removal of colon polyps to prevent the development of colon cancer
Intervention intended to reduce the recurrence or exacerbation of a disease
Secondary prevention
Example:
Use of a statin medication after a person has had a MI
Criteria for effective screening
- Disease should be of high enough prevalence to make the effort worthwhile
- Time frame during which the person is asymptomatic, but during which the disease/risk factor can be identified
- Available test that sufficient sensitivity and specificity, is cost-efective, and is acceptable to patients
- Must be an intervention that can be made during the asymptomatic period that will prevent the development of the disease or reduce the morbidity/mortality
Gold standard for clinical preventive medicine
USPSTF
(United States Preventive Services Task Force)
USPSTF grades
A: offer/provide this service
B: offer/provide this service
C: offer/provide only if there are other considerations that support offering/providing
D: discourage use of this service
I: insufficient evidence
When should screening begin for lipid disorders?
Level A:
Men >35
Women >45
Level B:
Adults >20 who are at increased risk for cardiovascular disease
Screening recommendation for abdominal aortic aneurysm
Level B for men 65-75 who have smoked at any point
Level C (no recommendation) for men who have never smoked
Level D for women, regardless of smoking status
Screening for colorectal cancer
Men and women older than 50
FOBT annually, sigmoidoscopy every 3-5 years, and colonoscopy every 10 years
*An abnormal FOBT or sigmoidoscopy leads to the performance of a colonoscopy
Tdap recommendation
All adults between 19 and 65 should receive a booster of Tdap in place of a scheduled dose of Td due to waning immunity against pertussis
Pneumococcal polysaccharide vaccination
Recommended as a single dose for all adults >65
*Recommended at a younger age for adults who are alcoholics/smokers, have chronic cardiovascular/pulmonary/renal/heptic disease, diabetes, an immunodeficiency, or who are functionally asplenic
62M with recently diagnosed emphysema presents to your office for a routine exam. He has not had any immunizations in more than 10 years. Which immunizations would be most appropriate for this individual?
Tdap
Pneumococcal (d/t chronic lung disease)
Influenza
Two most common causes of dyspnea and wheezing in adults
- COPD
- Asthma
Presents earlier in life, may or may not be associated with cigarette smoking, and is characterized by episodic exacerbations with return to relatively normal baseline lung functioning
Asthma
Presents in midlife or later, is usually the result of a long history of smoking, and is a slowly progressive disorder in which measured pulmonary functioning never returns to normal.
COPD
Mainstays of medical therapy for both asthma and COPD
- Oxygen
- Bronchodilators
- Steroids
Cough and sputum production on most days for at least 3 months during at least 2 consecutive years
Chronic bronchitis
Shortness of breath caused by the enlargement of respiratory bronchioles and alveoli (destruction of lung tissue and elastin)
Emphysema
Pink puffer: pink from polycythemia (2/2 chronic hypoxia), enlarged chest b/c lungs cannot deflate, and puffing because slow breaths = less obstruction
A rare cause of COPD that should be considered when emphysema develops at younger ages (<45), especially in nonsmokers
α1-antitrypsin deficiency
Pathologic changes in COPD
Mucous gland hypertrophy with hypersecretion, ciliary dysfunction, destruction of lung parenchyma, and airway remodeling
By the time dyspnea develops, lung function has been reduced by about half and the COPD has been present for years
Barrel Chest + Distant Heart Sounds
COPD
A result of hyperinflation of the lungs
FVC and FEV1 in COPD
Both the FVC and FEV1 are reduced, but the ratio of FEV1 to FVC is less than 0.7
*Reversibility is defined as an increase in FEV1 of greater than 12% or 200 mL
- Mild: FEV1 > 80*
- Moderate: FEV1 50-80*
- Severe: FEV1 30-50*
- Very Severe: FEV1 < 30*
Treatment for:
Mild COPD (FEV1 >80%)
Moderate COPD (FEV1 50-80%)
Severe COPD (FEV1 30-50%)
Very severe COPD (FEV1 <30%)
Mild: short-acting bronchodilators
Moderate: long-acting bronchodilators
Severe: inhaled steroids
Very severe: long-term oxygen therapy and consider surgical interventions